LIGAND PHARMACEUTICAL INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago.

The Company also expects to repay in full its remaining $18.0 million in debt by August 2014 per the existing repayment schedule.

Ligand Pharmaceuticals Inc. : Ligand Acquires Financial Rights to More Than 15 Fully-Funded Development Programs from Selexis SA.

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that data from preclinical studies evaluating Ligand's HepDirect?

(RTTNews.com) - Ligand Pharmaceuticals Inc ( LGND ) will host a conference call at 4:30 PM ETMay 8, 2013, to discuss its Q1 13 earnings results.

SAN DIEGO, CA, USA I May 14, 2013 I Ligand Pharmaceuticals Incorporated (LGND) announced today that its partner Rib-X Pharmaceuticals, Inc. has initiated a Phase 3 clinical trial of a Captisol-enabled� intravenous (IV) formulation of delafloxacin for ...

The local economy relies mostly on food processing, the pharmaceutical industry, chemical development, the financial industry, tourism, telecommunications, printing and publishing.

Ligand has established multiple alliances with the world's leading pharmaceutical companies including GlaxoSmithKline, Onyx Pharmaceuticals, Merck, Pfizer, Baxter International, Bristol-Myers Squibb, Celgene, Lundbeck Inc., Eli Lilly & Co., Spectrum ...

(RTTNews.com) - Ligand Pharmaceuticals Inc. ( LGND ) will present at the Bank of America 2013 Healthcare Conference in Las Vegas.

If you own common stock in Ligand Pharmaceuticals Incorporated and wish to obtain additional information, please contact Eduard Korsinsky, Esq.